Developing genetic medicines using an all-RNA gene insertion platform.
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Overview
Typewriter Therapeutics is developing genetic medicines using an all-RNA gene insertion platform (built on R2 retrotransposon technology) that inserts full-length therapeutic genes at a natural safe-harbor genomic site without viral vectors or double-strand breaks.
Typewriter Therapeutics Funding
Sign up to gain insights into Typewriter Therapeutics funding history, including the funding round, time period, and amount raised.
| Financing Round | Date | Amount | Price per share | Valuation |
|---|---|---|---|---|
| Round | Date | Amount | PPS | Valuation |
| Series A-1 | Sep 02, 2026 | 5M | ||
| Series A-2 | Sep 02, 2026 | 11M | ||
| Series A | Sep 02, 2026 | 40M |
Access the PPS, Valuation details, and a wealth of other data by signing up. Source: Nasdaq Private Market
Buy
Sign up to view historical trading trends and place an offer.
Sell
Understand share pricing, list anonymously, and benefit from transparent fees.
Typewriter Therapeutics Management Team
Investors
ANRI
AN Venture Partners
Gemseki
RA Capital Management
Typewriter Therapeutics Valuations & Financials
View real-time NPM data on Typewriter Therapeutics stock including daily Typewriter Therapeutics stock price estimates, valuation history, and historical share price information. Access Typewriter Therapeutics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Typewriter Therapeutics pricing across six independent market signals. Looking for private company due diligence data sources on Typewriter Therapeutics? Get in touch to learn more.
Similar Companies
like Typewriter Therapeutics
Podium
Enterprise Software
Customer messaging platform enabling companies to connect at critical touch points.
Eightfold ai
AI & Machine Learning
Operates a Talent Intelligence Platform that provides talent acquisition and management solutions.
Volta Insite
Industrials
Provides a platform that monitors electrical systems in real time to detect issues early and enable predictive maintenance and operational optimization.
Cerebrotech Medical Systems
Healthcare & Life Sciences
Provides fast brain fluid and electrical monitoring to enhance neurological assessment.
Revagenix
Healthcare & Life Sciences
Develops novel antibiotics to treat drug-resistant infections through advanced research.
Alation
Enterprise Software
The platform helps employees in data-driven organizations access, understand and govern data.
Clockworks Analytics
Industrials
Provides software that automates loan portfolio analysis, stress testing, and risk reporting for better financial planning and insight.
FAQ
We have answers
Typewriter Therapeutics stock does not trade on public stock exchanges. Typewriter Therapeutics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Typewriter Therapeutics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.
Learn more about the secondary market for private company shares on the investors page.
Typewriter Therapeutics Stock does not trade on public stock exchanges. In order to sell Typewriter Therapeutics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.
Learn more about NPM services for selling privately held stock on the Employee Shareholders page.
Read more about how to sell private company stock on the private secondary market:
Typewriter Therapeutics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Typewriter Therapeutics share price and other valuable private market data.
Read more about secondary market private company stock prices:
There is no ticker symbol for Typewriter Therapeutics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.
Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Typewriter Therapeutics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.
Learn more about selling privately held stock on the Employee Shareholders page.
Read more about how to sell shares of a private company and eligibility for selling privately held stock:
Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Typewriter Therapeutics stock, you need to be an accredited entity or institutional investor.
Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.
Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.
To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.
Typewriter Therapeutics is a private company and has not had an IPO. There is currently no Typewriter Therapeutics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Typewriter Therapeutics IPO.
Learn more about Data and Intelligence private company stock data for institutional investors on the on the NPM Data and Intelligence Product Page.
